Mortality in COPD: Causes, Risk Factors, and Prevention

被引:176
作者
Berry, Cristine E. [2 ]
Wise, Robert A. [1 ]
机构
[1] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21224 USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
关键词
COPD; Mortality; Anticholinergics; Beta-agonists; Inhaled corticosteroids; Oxygen; OBSTRUCTIVE PULMONARY-DISEASE; C-REACTIVE PROTEIN; LUNG-VOLUME-REDUCTION; AIR-FLOW OBSTRUCTION; INHALED CORTICOSTEROIDS; FLUTICASONE PROPIONATE; SURVIVAL BENEFIT; UNITED-STATES; FOLLOW-UP; PREDICTS MORTALITY;
D O I
10.3109/15412555.2010.510160
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Chronic obstructive pulmonary disease (COPD) is a leading and increasing cause of death, the extent of which is underestimated as a consequence of underdiagnosis and underreporting on death certificates. Data from large trials, such as the Lung Health Study, Towards a Revolution in COPD Health (TORCH), Understanding Potential Long-term Impacts on Function with Tiotropium (UPLIFT), European Respiratory Society Study on Chronic Obstructive Pulmonary Disease (EUROSCOP), and Inhaled Steroids in Obstructive Lung Disease (ISOLDE), have shown that the causes of death in patients with mild COPD are predominantly cancer and cardiovascular disease, but as COPD severity increases, deaths due to non-malignant respiratory disease are increasingly common. In practice, mortality of patients with COPD can be predicted by a variety of measures including: forced expiratory volume in one second (FEV1), the ratio of inspiratory and total lung capacities, exercise capacity, dyspnea scores, and composite indices such as the body-mass index (B), degree of airflow obstruction (O), degree of functional dyspnea (D), and exercise capacity (E) (BODE) index. Smoking cessation improves survival in COPD patients, and in select patients with advanced disease, oxygen therapy, lung volume reduction surgery, or lung transplantation may also improve survival.
引用
收藏
页码:375 / 382
页数:8
相关论文
共 60 条
[51]   Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease [J].
Soler-Cataluña, JJ ;
Martínez-García, MA ;
Sánchez, PR ;
Salcedo, E ;
Navarro, M ;
Ochando, R .
THORAX, 2005, 60 (11) :925-931
[52]   Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice [J].
Soriano, JB ;
Vestbo, J ;
Pride, NB ;
Kiri, V ;
Maden, C ;
Maier, WC .
EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (04) :819-825
[53]   Lung transplantation in patients with chronic obstructive pulmonary disease in a national cohort is without obvious survival benefit [J].
Stavem, K ;
Bjortuft, O ;
Borgan, O ;
Geiran, O ;
Boe, J .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (01) :75-84
[54]   Inhaled steroids and mortality in COPD: bias from unaccounted immortal time [J].
Suissa, S .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (03) :391-395
[55]   A 4-year trial of tiotropium in chronic obstructive pulmonary disease [J].
Tashkin, Donald P. ;
Celli, Bartolome ;
Senn, Stephen ;
Burkhart, Deborah ;
Kesten, Steven ;
Menjoge, Shailendra ;
Decramer, Marc .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (15) :1543-1554
[56]   Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease [J].
Thabut, Gabriel ;
Ravaud, Philippe ;
Christie, Jason D. ;
Castier, Yves ;
Fournier, Michel ;
Mal, Herve ;
Leseche, Guy ;
Porcher, Raphael .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (10) :1156-1163
[57]   Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease:: a retrospective analysis of registry data [J].
Thabut, Gabriel ;
Christie, Jason D. ;
Ravaud, Philippe ;
Castier, Yves ;
Brugiere, Olivier ;
Fournier, Michel ;
Mal, Herve ;
Leseche, Guy ;
Porcher, Raphael .
LANCET, 2008, 371 (9614) :744-751
[58]   Disease-Specific Survival Benefit of Lung Transplantation in Adults: A National Cohort Study [J].
Titman, A. ;
Rogers, C. A. ;
Bonser, R. S. ;
Banner, N. R. ;
Sharples, L. D. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (07) :1640-1649
[59]  
TRAVER GA, 1979, AM REV RESPIR DIS, V119, P895
[60]  
Zielinski J, 1997, Monaldi Arch Chest Dis, V52, P43